Abilify Maintena

Product Description

Abilify Maintena (Aripiprazole)is a prescription atypical antipsychotic medication formulated as a lyophilized powder for extended-release injectable suspension. The active ingredient, Aripiprazole, works by rebalancing dopamine and serotonin levels in the brain to improve thinking, mood, and behavior. It is specifically approved for the treatment of Schizophrenia in adults and for maintenance monotherapy treatment of Bipolar I Disorder.

Key Benefits of Monthly Administration
One of the primary challenges in treating mental health conditions is adhering to a daily pill regimen. Abilify Maintena addresses this by offering a once-monthly injection. This extended-release formula releases the medication slowly into the bloodstream over 30 days, ensuring consistent therapeutic levels without the peaks and troughs often associated with oral medications. This can significantly reduce the risk of relapse caused by missed doses.

How it is Administered
This medication must be administered by a healthcare professional. It is given as an intramuscular injection into either the deltoid (arm) or gluteal (buttock) muscle. It is not intended for self-administration. Patients starting Abilify Maintena may need to continue taking oral aripiprazole for the first 14 days to ensure adequate medication coverage during the initiation phase.

Important Safety Information
Abilify Maintena is not for patients with dementia-related psychosis. Common side effects may include weight gain, sedation, or injection site pain. Always consult your doctor regarding your full medical history, specifically regarding cardiovascular issues or diabetes, before starting this treatment